Overview
Welcome to Dwaey, specifically on RAPIDFLOX 250mg Tablets/Film-coated page.
This medicine contains an important and useful components, as it consists of Ciprofloxacin.
RAPIDFLOX 250mg is available in the market in concentration 250mg/Tablet and in the form of Tablets/Film-coated.
CIPLA LTD. is the producer of RAPIDFLOX 250mg and it is imported from INDIA, The most popular alternatives of RAPIDFLOX 250mg are listed downward .
Ciprofloxacin promotes breakage of double-stranded DNA in susceptible organisms and inhibits DNA gyrase, which is essential in reproduction of bacterial DNA.
Epilepsy, history of CNS disorders; severe renal or hepatic dysfunction; G6PD deficiency; maintain adequate hydration; myasthaenia gravis. Caution when used in patients with QT prolongation or risk factors e.g. bradycardia, pre-existing cardiac disease or uncorrected electrolyte disturbances. Discontinue treatment if patients experience tendon pain, inflammation or rupture. Avoid usage in methicillin-resistant staphylococcus aureus (MRSA) infections due to high level of resistance. May impair ability to drive or operate machinery. Safety and efficacy have not been established in pregnant and lactating women. Not to be used in children <18 yr; except where benefit clearly exceeds risk. Lactation: Drug enters breast milk; use not recommended (American Academy of Pediatrics Committee states that drug is compatible with nursing)
Hypersensitivity. Not to be used concurrently with tizanidine. Avoid exposure to strong sunlight or sun lamps during treatment.
Pregnancy category: C
Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks
Ciprofloxacin
Ciprofloxacin
Ciprofloxacin
Ciprofloxacin
Ciprofloxacin
Ciprofloxacin
Ciprofloxacin
Ciprofloxacin